Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema.
- 1 January 1998
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 16 (2) , 111-116
- https://doi.org/10.2165/00044011-199816020-00003
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema.1996
- Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream, 0.1%, in the treatment of moderate-to-severe psoriasis.1996
- Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema.1996
- Topical corticosteroids in clinical practice: focus on fluticasone propionate.1996
- Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema.1996
- Efficacy and safety of fluticasone propionate 0.005% ointment in the treatment of psoriasis.1996
- FLUTICASONE PROPIONATE IN THE TREATMENT OF INFLAMMATORY DERMATOSESInternational Journal Of Clinical Practice, 1995
- Binding kinetics of fluticasone propionate to the human glucocorticoid receptorSteroids, 1994
- Structure-activity relationships of topically active steroids: the selection of fluticasone propionateRespiratory Medicine, 1990
- The human pharmacology of fluticasone propionateRespiratory Medicine, 1990